Related Experiment Video
Updated: Sep 13, 2025

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
FABP4 Downregulated by FOS Alleviates Palmitic Acid-induced Endothelial Cell Dysfunction Via Inactivating ERK/STAT-1
1Department of Obstetrics, Zhuji People's Hospital of Zhejiang Province, Zhuji, Zhejiang, P.R. China.
Insights
Fatty acid-binding protein 4 (FABP4) is elevated in preeclampsia (PE). FABP4 interference protects against palmitic acid-induced endothelial cell dysfunction by inhibiting the ERK/STAT-1 pathway, potentially mediated by FOS.
Area of Science:
- Reproductive Biology
- Molecular Medicine
- Cellular Biology
Background:
- Preeclampsia (PE) is a serious pregnancy complication characterized by hypertension and organ damage.
- The underlying mechanisms of PE pathogenesis remain incompletely understood, necessitating further investigation into key molecular players.
- Fatty acid-binding protein 4 (FABP4) has been implicated in metabolic disorders, but its specific role in PE is unclear.
Purpose of the Study:
- To elucidate the role of FABP4 in the pathogenesis of preeclampsia (PE).
- To investigate the underlying molecular mechanisms by which FABP4 influences endothelial cell function in PE.
- To explore the potential involvement of the FOS protein in regulating FABP4 activity and its downstream signaling.
Main Methods:
- Quantification of FABP4 expression in blood and placental tissues from PE patients and controls using RT-qPCR.
- In vitro studies using human umbilical vein endothelial cells (HUVECs) treated with palmitic acid (PA) to mimic PE conditions.
- Manipulation of FABP4 and FOS expression via transfection (sh-FABP4, sh-FOS, Ov-FOS) and assessment of cell viability, apoptosis (TUNEL assay), migration, invasion (wound healing, Transwell assays), and angiogenesis (tube formation assay).
- Analysis of apoptosis-related proteins and the ERK/STAT-1 signaling pathway via Western blotting.
- Luciferase reporter and ChIP assays to determine FABP4 promoter activity and FOS binding to FABP4.
Main Results:
- FABP4 expression was significantly increased in the blood and placental tissues of PE patients and in PA-treated HUVECs.
- Interference with FABP4 expression reduced apoptosis and enhanced migration, invasion, and angiogenesis in PA-induced HUVECs by inactivating the ERK/STAT-1 signaling pathway.
- FOS was found to reduce FABP4 activity and inhibit the FABP4/ERK/STAT-1 signaling pathway, suggesting a protective role.
Conclusions:
- FABP4 plays a crucial role in the pathogenesis of preeclampsia by promoting endothelial cell dysfunction.
- FABP4 exacerbates PA-induced endothelial cell injury via activation of the ERK/STAT-1 signaling pathway.
- FOS may protect against PA-induced endothelial cell dysfunction by inhibiting the FABP4/ERK/STAT-1 pathway, highlighting a potential therapeutic target for PE.
Abstract:
This study aimed to explore the role and the mechanism of FABP4 in the pathogenesis of preeclampsia (PE). FABP4 expression in the whole blood and the placental tissue of PE patients and healthy pregnant women was detected using RT-qPCR. The transfection efficacy of sh-FABP4, sh-FOS and Ov-FOS was examined using Western blotting and RT-qPCR. CCK-8 assay was used to detect cell viability. TUNEL assay was used to detect cell apoptotic level. Wound healing and transwell assays were used to detect the migration and invasion of HUVECs. Tube formation assay was used to detect HUVEC s' angiogenic ability. Western blotting was used to measure the expressions of apoptosis- and ERK/STAT-1 signaling pathway-related proteins. Luciferase reporter assay was used to detect FABP4 promoter activity, while ChIP assay confirmed the binding ability of FOS to FABP4. FABP4 expression was increased in the whole blood and the placental tissue of PE patients and palmitic acid (PA)-treated HUVECs. FABP4 interference inhibited apoptosis while promoting the migration, invasion, and angiogenesis in PA-induced HUVECs via inactivating ERK/STAT-1. It was also identified that FOS reduced FABP4 activity and inhibited FABP4/ERK/STAT-1 signaling pathway. FABP4 protected against PA-induced endothelial cell dysfunction via the inhibition of ERK/STAT-1, which might be mediated by FOS.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
cAMP-dependent Protein Kinase Pathways
Peripheral Artery Disease I: Introduction

